Fillers

Part of our complete guide to Periocular Rejuvenation — this page covers dermal fillers in depth.

Dermal Fillers — Overview

Dermal fillers restore volume and improve facial contour in areas affected by aging, sun damage, or natural anatomy. Unlike neuromodulators, which relax muscles to soften dynamic wrinkles, fillers physically occupy space beneath the skin — adding volume, smoothing folds, and restoring structural support. Oculoplastic surgeons are expert injectors for periorbital filler treatments, where precise anatomical knowledge is essential to both achieve natural results and avoid rare but serious complications.

Hyaluronic Acid Fillers

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan that retains water and gives skin its plumpness. HA fillers are cross-linked to increase longevity and come in varying particle sizes and viscosities for different depths and areas of treatment. The critical safety advantage of HA fillers is their reversibility — an enzyme called hyaluronidase that can break down HA filler (often requiring adequate dosing and sometimes more than one treatment).

Tear Trough & Periorbital Filler

The tear trough — the concave groove at the junction of the lower eyelid and cheek — is one of the most requested and technically demanding filler treatments. As the midface descends with age and orbital fat herniates forward, this groove deepens and creates a shadow that imparts a tired, hollow appearance even in well-rested patients.

• A thin-caliber, low-viscosity HA filler is placed in the deep fat compartment over the inferior orbital rim
• Cannula technique is preferred to reduce bruising and the risk of intravascular injection in this high-risk area
• Conservative treatment is the rule — over-correction produces a puffy, unnatural appearance difficult to reverse
• Tyndall effect: a bluish-gray discoloration from superficially placed HA is a known complication, resolved with hyaluronidase
• Patients with significant lower lid fat herniation may benefit more from lower blepharoplasty than from fillers alone

Midface & Cheek Volume

Midface volume loss is one of the earliest signs of facial aging — the malar fat pad descends, deepening the nasolabial fold and creating a triangular "skeletonized" appearance. High-viscosity fillers (Voluma, Restylane Lyft) placed in the deep fat compartments or at the periosteum restore structural support, elevate descended soft tissues, and improve the nasolabial fold indirectly:

• Injected in the deep medial cheek fat, submalar region, or directly on the malar eminence
• Results last 12–24 months; among the longest-lasting applications for HA fillers
• Natural-appearing results require symmetric bilateral treatment with attention to facial proportions

Nasolabial Folds & Marionette Lines

The nasolabial fold (the crease from nose to mouth corner) and marionette lines (from the mouth corner toward the chin) deepen as midface tissues descend. Mid-viscosity HA fillers can be placed directly within these folds or used in combination with cheek volume restoration for a lifting effect. True improvement often comes from treating the structural cause (midface descent) rather than the fold itself.

Lip Augmentation

HA fillers define the vermilion border, increase lip volume, and reduce perioral lines. Precise injection into the lip body (wet vermilion), white roll (vermilion border), philtral columns, and Cupid's bow defines lip architecture. Natural-appearing results:

• Preserve the natural lip ratio (upper:lower = approximately 1:1.6)
• Avoid the "duck lip" deformity from over-projection of the central upper lip
• Address perioral lines by placing filler just beneath the skin along the vermilion border
• Lip filler typically lasts 6–12 months due to the high mobility of the lip

Biostimulatory Fillers

Unlike HA fillers, biostimulatory agents work by stimulating the patient's own collagen production over months. They are not reversible.

• Sculptra® (poly-L-lactic acid) — stimulates fibroblast-mediated collagen synthesis over 3–6 months. Injected in the deep fat compartments of the cheeks, temples, and jawline over 2–3 sessions. Results last 2+ years. Ideal for diffuse volume loss and skin laxity rather than discrete folds.
• Radiesse® (calcium hydroxylapatite) — immediate volumizing effect plus collagen stimulation. FDA-approved for cheeks, nasolabial folds, and hands. More viscous than HA fillers; best used in deeper planes. Not reversible with hyaluronidase.

Reversibility: Hyaluronidase

Hyaluronidase (Vitrase®, Hylenex®) is an enzyme that dissolves hyaluronic acid — making HA fillers uniquely reversible. It is used for:

• Overcorrection or asymmetry after HA filler
• Tyndall effect (superficially placed HA appearing blue)
• Delayed inflammatory nodules
• Vascular occlusion emergency — immediate high-dose hyaluronidase is the primary treatment for cutaneous vascular compromise; however, in cases of vision loss from ophthalmic artery occlusion, treatment efficacy is limited and outcomes are frequently irreversible, making prevention and immediate emergency care essential

Biostimulatory fillers (Sculptra, Radiesse) are not reversible and require greater precision at injection.

Risks & Complications

• Bruising and swelling — common; resolves in days to 2 weeks. Cannula technique reduces bruising.
• Nodules — from superficial placement, product migration, or inflammatory reaction. Treated with hyaluronidase, intralesional steroids, or antibiotics depending on type.
• Tyndall effect — bluish discoloration from superficial HA; resolved with hyaluronidase.
• Delayed inflammatory reaction — can occur months to years after HA injection, often triggered by viral illness or dental procedures. Treated with hyaluronidase plus antibiotics or steroids.
• Vascular occlusion — the most feared complication; intravascular HA injection can occlude arteries supplying skin (causing necrosis) or the ophthalmic artery (causing vision loss). Risk is minimized by: anatomical knowledge, use of cannulas, low injection pressure, slow injection, and aspiration (which has a high false-negative rate and should not be relied upon alone). Requires immediate recognition and high-dose hyaluronidase. The periorbital and nasal areas carry the highest risk of vision-threatening vascular complications.